Literature DB >> 15047247

Superior vena cava syndrome during chemotherapy for stage 3c fallopian tube adenocarcinoma.

David Griffin1, Martin A Martino, Mitchell S Hoffman.   

Abstract

BACKGROUND: Superior vena cava syndrome is most often encountered in patients with malignancies. The diagnosis constitutes an oncologic emergency with prompt treatment indicated to manage the acute symptoms. There are few reports describing the syndrome in patients with gynecologic malignancies and central venous catheters. Management has included treatment of the metastatic disease and anticoagulation/thrombolysis with catheter removal early in therapy. CASE REPORT: The case described is the first report of a patient with fallopian tube carcinoma complicated by SVC syndrome. The complication was attributed to an implanted venous access port being utilized to give adjuvant combination chemotherapy.
CONCLUSIONS: Superior vena cava syndrome is rarely encountered in gynecologic oncology patients and constitutes a medical emergency. When encountered in the setting of an implanted catheter, thrombolysis and anticoagulation is an alternative to catheter removal in selected patients.

Entities:  

Mesh:

Year:  2004        PMID: 15047247     DOI: 10.1016/j.ygyno.2003.12.007

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  1 in total

1.  Superior vena cava syndrome associated with uterine serous carcinoma.

Authors:  Anya Laibangyang; Raanan Alter; Yasmin Hasan; S Diane Yamada
Journal:  Gynecol Oncol Rep       Date:  2020-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.